Literature DB >> 20424935

The obesity paradox and cardiovascular disease.

Stephen A Morse1, Rajat Gulati, Efrain Reisin.   

Abstract

Obesity is increasingly recognized as a global pandemic that threatens the health of millions of people. Obesity is considered to be an important cardiovascular risk factor, but there is increasing evidence that patients with elevated body mass index may be better off than others if they develop cardiovascular or renal disease. This phenomenon has been described as the "obesity paradox" or "reverse epidemiology." This article reviews some recent publications that have studied this phenomenon as it relates to heart failure, coronary artery disease, peripheral arterial disease, kidney disease, and a cohort of patients undergoing nonbariatric surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424935     DOI: 10.1007/s11906-010-0099-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  20 in total

1.  Cardiovascular mortality in overweight subjects: the key role of associated risk factors.

Authors:  Frédérique Thomas; Kathryn Bean; Bruno Pannier; Jean-Michel Oppert; Louis Guize; Athanase Benetos
Journal:  Hypertension       Date:  2005-09-12       Impact factor: 10.190

2.  The "obesity paradox": is smoking/lung disease the explanation?

Authors:  Carl J Lavie; Hector O Ventura; Richard V Milani
Journal:  Chest       Date:  2008-11       Impact factor: 9.410

3.  An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry.

Authors:  Gregg C Fonarow; Preethi Srikanthan; Maria Rosa Costanzo; Guillermo B Cintron; Margarita Lopatin
Journal:  Am Heart J       Date:  2007-01       Impact factor: 4.749

4.  The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative.

Authors:  Deborah B Diercks; Matthew T Roe; Jyotsna Mulgund; Charles V Pollack; J Douglas Kirk; W Brian Gibler; E Magnus Ohman; Sidney C Smith; William E Boden; Eric D Peterson
Journal:  Am Heart J       Date:  2006-07       Impact factor: 4.749

5.  Secular trends in cardiovascular disease risk factors according to body mass index in US adults.

Authors:  Edward W Gregg; Yiling J Cheng; Betsy L Cadwell; Giuseppina Imperatore; Desmond E Williams; Katherine M Flegal; K M Venkat Narayan; David F Williamson
Journal:  JAMA       Date:  2005-04-20       Impact factor: 56.272

6.  Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.

Authors:  Kamyar Kalantar-Zadeh; Joel D Kopple; Ryan D Kilpatrick; Charles J McAllister; Christian S Shinaberger; David W Gjertson; Sander Greenland
Journal:  Am J Kidney Dis       Date:  2005-09       Impact factor: 8.860

7.  Obesity, end-stage renal disease, and survival in an elderly cohort with cardiovascular disease.

Authors:  Janice P Lea; Daryl O Crenshaw; Stephen J Onufrak; Britt B Newsome; William M McClellan
Journal:  Obesity (Silver Spring)       Date:  2009-03-26       Impact factor: 5.002

8.  The obesity paradox, weight loss, and coronary disease.

Authors:  Carl J Lavie; Richard V Milani; Surya M Artham; Dharmendrakumar A Patel; Hector O Ventura
Journal:  Am J Med       Date:  2009-08-13       Impact factor: 4.965

9.  Obesity paradox in patients with hypertension and coronary artery disease.

Authors:  Seth Uretsky; Franz H Messerli; Sripal Bangalore; Annette Champion; Rhonda M Cooper-Dehoff; Qian Zhou; Carl J Pepine
Journal:  Am J Med       Date:  2007-10       Impact factor: 4.965

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  29 in total

1.  In vivo analysis of white adipose tissue in zebrafish.

Authors:  James E N Minchin; John F Rawls
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

2.  Drug treatment for obesity in the post-sibutramine era.

Authors:  Bernard M Y Cheung
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

Review 3.  The obesity paradox in diabetes.

Authors:  Mercedes R Carnethon; Laura J Rasmussen-Torvik; Latha Palaniappan
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

4.  Bariatric surgery in class I obesity : a Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

Authors:  Luca Busetto; John Dixon; Maurizio De Luca; Scott Shikora; Walter Pories; Luigi Angrisani
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

Review 5.  Clinical research in cardiac rehabilitation and secondary prevention: looking back and moving forward.

Authors:  Patrick D Savage; Bonnie K Sanderson; Todd M Brown; Kathy Berra; Philip A Ades
Journal:  J Cardiopulm Rehabil Prev       Date:  2011 Nov-Dec       Impact factor: 2.081

6.  Impaired compensation to femoral artery ligation in diet-induced obese mice is primarily mediated via suppression of collateral growth by Nox2 and p47phox.

Authors:  Matthew R DiStasi; Julie A Mund; H Glenn Bohlen; Steven J Miller; David A Ingram; Michael C Dalsing; Joseph L Unthank
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-21       Impact factor: 4.733

7.  Public health ethics and obesity prevention: the trouble with data and ethics.

Authors:  Udo Schuklenk; Erik Yuan Zhang
Journal:  Monash Bioeth Rev       Date:  2014 Mar-Jun

Review 8.  In vivo imaging and quantification of regional adiposity in zebrafish.

Authors:  J E N Minchin; J F Rawls
Journal:  Methods Cell Biol       Date:  2016-12-26       Impact factor: 1.441

9.  'Obesity paradox' misunderstands the biology of optimal weight throughout the life cycle.

Authors:  J B Dixon; G J Egger; E A Finkelstein; J G Kral; G W Lambert
Journal:  Int J Obes (Lond)       Date:  2014-04-15       Impact factor: 5.095

10.  Exploring The Obesity Paradox In Atrial Fibrillation. AFBAR (Atrial Fibrillation Barbanza Area) Registry Results.

Authors:  M Cristina González-Cambeiro; Emad Abu-Assi; Sergio Raposeiras-Roubín; Moisés Rodríguez-Mañero; Fernando Otero-Raviña; José R González-Juanatey; Genaro Gutiérrez-Fernández; Rosa Liñares-Stolle; Jorge Alvear-García; Mª Jesús Eirís-Cambre; Carmen Cerqueiras-Alcalde; Mª José Vázquez López; Ángel Lado-Llerena
Journal:  J Atr Fibrillation       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.